Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02517879
Other study ID # 003
Secondary ID
Status Completed
Phase N/A
First received July 27, 2015
Last updated August 4, 2015
Start date November 2013
Est. completion date May 2014

Study information

Verified date August 2015
Source IDinsight
Contact n/a
Is FDA regulated No
Health authority Zambia: Ministry of Health
Study type Interventional

Clinical Trial Summary

All households in three zones in Zambia's Eastern Province were invited to attend a community point distribution of insecticide treated bed nets (ITNs). Households were then randomized to different intervals for a community health worker (CHW) hang-up visit.


Description:

Households were asked to attend a community point distribution of ITNs in one of three zones in Zambia's Eastern Province. Households that had been registered to receive ITNs were then randomized to one of five groups that received a CHW visit at different intervals. Group 1 was visited 1-3 days after distribution, group 2 was visited 5-7 days after, group 3 was visited 10-12 days after, group 4 was visited 15-17 days after, and group 5 did not receive a hang-up visit. Groups 1-4 were categorized as having received a hang-up visit and group 5 was categorized as not having received a hang-up visit. All households in all five groups were visited at 7-11 weeks after the distribution and again at 5-6 months after the distribution to assess short- and medium-term ITN retention and usage.


Recruitment information / eligibility

Status Completed
Enrollment 560
Est. completion date May 2014
Est. primary completion date May 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Household was pre-registered by the National Malaria Control Centre to receive ITNs ahead of the start of study activities.

- Household was located in one of the three study areas of Mukonka, Lukwipa, and Chipeketi in Rufunsa District, Zambia

Exclusion Criteria:

- Household was not pre-registered to receive ITNs

- Household was not located in one of the three study areas

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
Community point distribution
Households were invited to a central location in their community (i.e. school, church, etc) where they received their allotment of ITNs (one per sleeping space, as pre-registered ahead of study activities). Households were provided with malaria prevention messaging at the distribution. They were called up one-by-one in front of other members of the community to mitigate misrepresentation of households.
Community health worker hang-up visit
CHWs visited households to take stock of how many ITNs that were distributed during the distribution were hung and to hang any unhung ITNs.

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
IDinsight Clinton Health Access Initiative Inc., Ministry of Health, Zambia, National Malaria Control Centre, Zambia

Outcome

Type Measure Description Time frame Safety issue
Primary Community point distribution attendance The percentage of pre-registered households that collected ITNs at the community point distributions on November 14, 19, and 21, 2013. At time 0 No
Primary Self-installation of ITNs The percentage of ITNs distributed to a household that the CHW found hanging at his/her visit. Each group is randomized to receive a community health worker visit after a different duration, an average of 7 days after the point distribution No
Primary Household ITN retention The percentage of ITNs distributed to a household that were found still in the household at the 7-11 week follow-up. An average of 9 weeks after community point distribution No
Primary Household ITN retention The percentage of ITNs distributed to a household that were found still in the household at the 5-6 month follow-up. An average of 5.5 months after community point distribution No
Primary Household percentage of ITNs hung The percentage of ITNs distributed to a household that were found hanging during the 7-11 week follow-up. An average of 9 weeks after community point distribution No
Primary Household percentage of ITNs hung The percentage of ITNs distributed to a household that were found hanging during the 5-6 month follow-up. An average of 5.5 months after community point distribution No
Primary Household percentage of sleeping spaces covered The percentage of sleeping spaces in the household that were covered by an ITN distributed during the community point distribution at the 7-11 week follow-up. An average of 9 weeks after community point distribution No
Primary Household percentage of sleeping spaces covered The percentage of sleeping spaces in the household that were covered by an ITN distributed during the community point distribution at the 5-6 month follow-up. An average of 5.5 months after community point distribution No
See also
  Status Clinical Trial Phase
Completed NCT04601714 - Baseline Cohort Malaria Morbidity Study
Withdrawn NCT04020653 - A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria Phase 2
Terminated NCT04368910 - Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria Phase 3
Completed NCT03641339 - Defining Skin Immunity of a Bite of Key Insect Vectors in Humans N/A
Completed NCT02544048 - Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
Completed NCT00527163 - Role of Nitric Oxide in Malaria
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Active, not recruiting NCT04704674 - Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
Completed NCT03276962 - Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age Phase 2
Completed NCT04966871 - Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults Phase 1
Completed NCT00289185 - Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants Phase 2
Recruiting NCT03937817 - Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Active, not recruiting NCT06153862 - Africa Ready Malaria Screening N/A
Completed NCT04545905 - Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
Recruiting NCT06278181 - Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
Completed NCT02909712 - Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania Phase 2
Withdrawn NCT02793414 - Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
Withdrawn NCT02793388 - A Trial on Supervised Primaquine Use in Ethiopia Phase 4
Completed NCT02793622 - Prevention of Malaria in HIV-uninfected Pregnant Women and Infants Phase 3
Completed NCT02315690 - Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland Phase 3